Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension
Related Experiment Video
Updated: Apr 27, 2026

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
François Potus1, Simon Malenfant, Colin Graydon
1Pulmonary Hypertension Research Group, Quebec Heart and Lung Institute Research Center, Laval University, Quebec City, Canada.
Rationale:
Pulmonary arterial hypertension (PAH) is characterized by significant exercise intolerance, which is multifactorial and involves skeletal muscle alterations. There is growing evidence that microRNAs (miRs) are involved in PAH pathogenesis.
Objectives:
We hypothesized that miR-126, an endothelial-specific, proangiogenic miR, is down-regulated in the peripheral muscles of patients with PAH, which would account for skeletal muscle microcirculation loss and exercise intolerance.
Measurements And Main Results:
Patients with PAH displayed decreases in exercise capacity ([Formula: see text]o2max) and microcirculation loss on quadriceps muscle biopsy (in CD31(+) immunofluorescence experiments) compared to control subjects. Exercise capacity correlated with muscle capillarity (r = 0.84, P < 0.01). At the cellular level, vascular endothelial growth factor (VEGF) and VEGF receptor 2 expression were similar in both groups. Conversely, PAH was associated with a 60% decrease in miR-126 expression in a quantitative reverse transcriptase polymerase chain reaction experiment (P < 0.01), resulting in up-regulation of its targeted protein, Sprouty-related, EVH1 domain-containing protein 1 (SPRED-1), and a marked decrease in the downstream effectors of the VEGF pathway, p-Raf/Raf and p-ERK/ERK, as determined by immunoblot analysis. Using freshly isolated CD31(+) cells from human quadriceps biopsies, we found that the down-regulation of miR-126 in PAH triggered the activation of SPRED-1, impairing the angiogenic response (Matrigel assay). These abnormalities were reversed by treating the PAH cells with miR-126 mimic, whereas inhibition of miR-126 (antagomir) in healthy CD31(+) cells fully mimicked the PAH phenotype. Finally, miR-126 down-regulation in skeletal muscle of healthy rats decreased muscle capillarity in immunofluorescence assays (P < 0.05) and exercise tolerance in treadmill tests (P < 0.05), whereas miR-126 up-regulation increased them in monocrotaline PAH rats.
Conclusions:
We demonstrate for the first time that exercise intolerance in PAH is associated with skeletal muscle microcirculation loss and impaired angiogenesis secondary to miR-126 down-regulation.
Insights
Pulmonary arterial hypertension (PAH) causes exercise intolerance due to reduced muscle microcirculation. This study reveals that down-regulated microRNA-126 (miR-126) in skeletal muscle impairs blood vessel growth, contributing to PAH symptoms.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Exercise Physiology
Background:
- Pulmonary arterial hypertension (PAH) significantly limits exercise capacity.
- Skeletal muscle alterations and microRNA (miRNA) dysregulation are implicated in PAH pathogenesis.
Purpose of the Study:
- To investigate the role of miR-126 in skeletal muscle microcirculation and exercise intolerance in PAH patients.
- To test the hypothesis that reduced miR-126 in peripheral muscles contributes to PAH-related exercise limitations.
Main Methods:
- Compared exercise capacity and quadriceps muscle microcirculation (CD31+ staining) in PAH patients and controls.
- Quantified miR-126 expression and analyzed downstream protein targets (SPRED-1, VEGF pathway) in muscle biopsies.
- Utilized cell culture assays (Matrigel) and animal models (rats) to confirm miR-126 function.
Main Results:
- PAH patients showed reduced exercise capacity and muscle capillarity, correlating with decreased miR-126 expression.
- Down-regulated miR-126 led to increased SPRED-1 and impaired VEGF signaling, hindering angiogenesis.
- Restoring miR-126 improved angiogenic capacity in PAH cells; inhibiting miR-126 mimicked PAH phenotype in healthy cells.
Conclusions:
- Exercise intolerance in PAH is linked to skeletal muscle microcirculation loss and impaired angiogenesis.
- Down-regulation of miR-126 is a key mechanism driving these skeletal muscle abnormalities in PAH.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Peripheral Artery Disease IV: Nursing Management

